What is the pathogenesis of cutaneous lupus erythematosus?

Pathogenesis of Cutaneous Lupus Erythematosus

Core Pathogenic Mechanism

Cutaneous lupus erythematosus results from a fundamental breakdown in immune tolerance, leading to autoantibody production, immune complex deposition at the dermal-epidermal junction, complement activation, and subsequent inflammatory tissue damage. 1, 2

Genetic Susceptibility

The genetic foundation involves multiple polymorphisms that increase disease risk:

• MHC (Major Histocompatibility Complex) gene polymorphisms are strongly associated with increased susceptibility to autoimmune reactions and CLE development 1
• Individual susceptibility is determined by combinations of specific polymorphisms in genes encoding cytokines, adhesion molecules, and cellular proteins, leading to abnormal expression of immunoregulatory molecules 3
• Genetic predisposition represents the greatest single risk factor for developing cutaneous lupus 3

Environmental Triggers

Ultraviolet Radiation (Primary Trigger)

• UV exposure induces keratinocyte apoptosis, which is the critical initiating event in photosensitive CLE 4, 5
• Impaired clearance of apoptotic cells allows accumulation of cellular debris and autoantigen exposure 4
• UV radiation causes externalization of autoantigens (particularly Ro/SSA) on keratinocyte surfaces, exposing them to circulating autoantibodies 4, 5
• UV exposure upregulates Ro52 antigen in keratinocytes, and abnormal Ro52 function contributes to uncontrolled inflammation in genetically susceptible individuals 5

Drug-Induced Mechanisms

• Certain medications trigger CLE through disruption of central tolerance and altered T cell function 4

Immune Cell Infiltration and Dysfunction

T Cell Abnormalities

• Th17 cells infiltrate CLE skin lesions and contribute to inflammatory tissue damage 4
• Regulatory T cells (Tregs) are decreased in lesional skin, contributing to breakdown of self-tolerance 4

Dendritic Cell Dysregulation

• Epidermal Langerhans cells are reduced in CLE lesions 4
• Plasmacytoid dendritic cells are increased in CLE lesions, playing a central role in pathogenesis through type I interferon production 4

Additional Cellular Infiltrates

• T cells, B cells, neutrophils, antigen-presenting cells, and NK cells all infiltrate lesional skin in response to genetic and environmental triggers 6

Autoantibody Production and Immune Complex Formation

• Autoantibodies against nuclear components are pathogenic and present in virtually all lupus patients 7, 1, 2
• Immune complexes deposit at the dermal-epidermal junction, creating the characteristic immunofluorescence pattern on biopsy 6
• Anti-Ro/SSA autoantibodies are particularly associated with photosensitive cutaneous lupus 5

Cytokine-Mediated Inflammation

Type I Interferon Pathway (Central Mechanism)

• Type I interferon is upregulated in CLE lesions and represents a common pathogenic denominator 7, 4
• Dysregulation of type I interferon signaling occurs in both innate and adaptive immune systems 7

Pro-inflammatory Cytokines

• TNF-α is upregulated in CLE lesions 4
• IL-6 and IL-17 are implicated in CLE pathogenesis 4

Complement Activation

• Immune complex deposition activates the complement cascade, recruiting inflammatory cells and causing tissue damage 1
• Complement dysregulation is characteristic of lupus pathophysiology 7

Interface Dermatitis Development

• The final common pathway is interface dermatitis, characterized by basal keratinocyte damage, inflammatory cell infiltration at the dermal-epidermal junction, and tissue destruction 6

Clinical Pitfall

The Ro52 autoantigen functions as a negative feedback regulator of inflammation through its E3 ligase activity. Loss of Ro52 function results in uncontrolled inflammation following minor skin injury, suggesting that Ro52 dysfunction or dysregulation is a critical pathogenic mechanism in UV-induced CLE. 5 This explains why anti-Ro/SSA-positive patients form a distinct photosensitive cluster within the CLE population.